Improving Sleep Quality, Psychosocial Functioning, and Cancer Related Fatigue With Light Therapy

ClinicalTrials.gov · COMPLETED, 2020

166 participants

Abstract

Cancer related fatigue (CRF) is one of the most prevalent and distressing long-term complaints reported by (non-) Hodgkin survivors. The SPARKLE study will test the efficacy of two intensities of light therapy on cancer related fatigue. Additionally, it explores possible working mechanisms of light therapy on CRF including improvements in sleep quality, psychosocial variables (depression, anxiety, cognitive complaints, and quality of life), and changes in biological circadian rhythms.

Conditions: Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma.

Primary outcome: Cancer related fatigue; Cancer related fatigue; Cancer related fatigue.

Enrollment: 166 participants.

How strong is the evidence?

Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 166 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

• ClinicalTrials.gov
• Publisher page

Related studies

• A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Evaluating the Evidence Base of Melatonin, Light Exposure, Exercise, and Complementary and Alternative Medicine for Patients with Insomnia Disorder Journal of Clinical Medicine, 2020
• Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis Journal of Clinical Medicine, 2022
• Influence of evening light exposure on polysomnographically assessed night-time sleep: A systematic review with meta-analysis Lighting Research & Technology, 2022
• Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation EClinicalMedicine, 2023
• Significant potential of melatonin therapy in Parkinson’s disease – a meta-analysis of randomized controlled trials Frontiers in Neurology, 2023
• Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders Focus, 2018

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free